Integrichain Blog

Blog

ICyte Platform Josh Halpern
December 1, 2022

Entering the New Era of Data-Driven Drug Commercialization

5 Minute Read

Co-Founder and Chief Operating Officer Josh Halpern reviews key industry trends impacting product commercialization and access, including the shift to true data-driven commercialization, highlighted at the Access Insights Conference...

ICyte Platform Josh Halpern
March 7, 2022

Unifying IntegriChain’s Services & Support: Customer Support and Value Realization

4 Minute Read

In his second unification-focused blog, President and COO Josh Halpern discusses IntegriChain's investment in customer support to better augment the value for customers and end-users.

ICyte Platform Josh Halpern
February 15, 2022

Unifying IntegriChain’s Services & Support: Data Management

4 Minute Read

President and COO Josh Halpern discusses the current and future capabilities of the integrated applications, analytics, and datastores within the ICyte Platform.

ICyte Platform Josh Halpern
November 23, 2021

A Look Back at the 2021 Access Insights Conference

2 Minute Read

Co-founder and EVP Josh Halpern reviews the recent Access Insights Conference and some of the key challenges that Life Sciences market access teams face.

ICyte Platform Kevin E. Leininger
October 29, 2021

15 Years Strong

2 Minute Read

Founder and CEO Kevin Leininger celebrates IntegriChain's outstanding customers and our team of professionals around the globe on our 15th anniversary.

ICyte Platform Josh Halpern
July 8, 2021

Breaking down the Silos for Next-Generation Access

5 Minute Read

This blog is the fourth in a series that shares our vision for future-proofing Market Access. Manufacturers can evolve the Market Access function to work toward their commercial, financial, and...

ICyte Platform Josh Halpern
June 17, 2021

Operational Goals to Future Proof Market Access

3 Minute Read

In this third installment, we look at operational goals for Market Access. Commercial Operations and Contracting teams need a flexible infrastructure that can support business scale and the changing...

pharma digital transformation

ICyte Platform Josh Halpern
June 3, 2021

Financial Goals to Future Proof Market Access

3 Minute Read

In this four-part series, we examine the key goals of Market Access teams as they look to the future with the advent of speciality and precision medicine and how...

340b contract pharmacy

ICyte Platform Josh Halpern
May 20, 2021

Future Proofing Market Access with a Unified Data and Technology Platform

4 Minute Read

This is the first of a series examining the commercial, financial, and operational goals of Market Access, which are all are stymied by data and application silos.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article